Covaxin stock runs out for 18-44 age group, 125 centres to be shut: AAP MLA

Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to shut 125 centres where the coronavirus vaccine was being administered, says AAP MLA Atishi

Covaxin stock runs out for 18-44 age group, 125 centres to be shut: AAP MLA
Press Trust of India New Delhi
1 min read Last Updated : May 11 2021 | 6:25 PM IST

Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to shut 125 centres where the coronavirus vaccine was being administered, AAP MLA Atishi said on Tuesday.

In an online briefing, she also said Delhi will get 2.67 lakh more doses of Covishield vaccine from the Centre by Tuesday evening.

"We have run out of Covaxin stock for 18-44 age group and will have to shut 125 centres where it is being administered after Tuesday evening," Atishi said.

The Aam Aadmi Party (AAP) leader urged the Centre to replenish Covaxin and Covishield stocks and said otherwise "we will have no option but to stop vaccination drive".

She said that more than 1.39 lakh people were given vaccine jabs in the national capital on May 10, the highest daily figure since the inoculation started.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAtishi MarlenaCoronavirus VaccineAAP

First Published: May 11 2021 | 6:22 PM IST

Next Story